Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Nicotine is a developmental neurotoxicant and neuroprotectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos.

Publication ,  Journal Article
Qiao, D; Seidler, FJ; Violin, JD; Slotkin, TA
Published in: Brain Res Dev Brain Res
December 30, 2003

Although nicotine is now well recognized as a developmental neurotoxicant, it also may have neuroprotectant properties. In the current study, we used PC12 cells to characterize the specific developmental phases in which these effects are expressed. In undifferentiated cells, nicotine had a modest effect on DNA synthesis (10% reduction), which was nevertheless selective, as no significant reductions were seen for RNA or protein synthesis. The effects were blocked by mecamylamine, indicating mediation by nicotinic acetylcholine receptors. Initiation of differentiation with nerve growth factor, which greatly increases the receptor concentration, produced a commensurate increase in the sensitivity of DNA synthesis to nicotine, while RNA and protein synthesis again remained unaffected. The organophosphate insecticide, chlorpyrifos, also interferes with DNA synthesis in undifferentiated PC12 cells, but by mechanisms independent of nicotinic receptors. Accordingly, the effects of a combination of nicotine and chlorpyrifos should be additive. However, simultaneous exposure of undifferentiated cells to both agents produced less-than-additive effects at low concentrations of chlorpyrifos, and at high chlorpyrifos concentrations, nicotine produced outright protection: the combination of nicotine and chlorpyrifos had lesser effects than chlorpyrifos alone. The same neuroprotection was seen when cells were exposed to nicotine for 24 h, washed free of the drug for 24 h, and then exposed to chlorpyrifos. The results indicate that nicotine interferes with neural cell replication, with peak effects in early stages of differentiation. At the same time, nicotine promotes trophic actions that protect against neurotoxicants that work through other mechanisms.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Brain Res Dev Brain Res

DOI

ISSN

0165-3806

Publication Date

December 30, 2003

Volume

147

Issue

1-2

Start / End Page

183 / 190

Location

Netherlands

Related Subject Headings

  • Receptors, Nicotinic
  • Rats
  • RNA
  • PC12 Cells
  • Nucleic Acid Synthesis Inhibitors
  • Nicotinic Antagonists
  • Nicotinic Agonists
  • Nicotine
  • Neurotoxicity Syndromes
  • Neuroprotective Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Qiao, D., Seidler, F. J., Violin, J. D., & Slotkin, T. A. (2003). Nicotine is a developmental neurotoxicant and neuroprotectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos. Brain Res Dev Brain Res, 147(1–2), 183–190. https://doi.org/10.1016/s0165-3806(03)00222-0
Qiao, Dan, Frederic J. Seidler, Jonathan D. Violin, and Theodore A. Slotkin. “Nicotine is a developmental neurotoxicant and neuroprotectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos.Brain Res Dev Brain Res 147, no. 1–2 (December 30, 2003): 183–90. https://doi.org/10.1016/s0165-3806(03)00222-0.
Qiao, Dan, et al. “Nicotine is a developmental neurotoxicant and neuroprotectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos.Brain Res Dev Brain Res, vol. 147, no. 1–2, Dec. 2003, pp. 183–90. Pubmed, doi:10.1016/s0165-3806(03)00222-0.
Journal cover image

Published In

Brain Res Dev Brain Res

DOI

ISSN

0165-3806

Publication Date

December 30, 2003

Volume

147

Issue

1-2

Start / End Page

183 / 190

Location

Netherlands

Related Subject Headings

  • Receptors, Nicotinic
  • Rats
  • RNA
  • PC12 Cells
  • Nucleic Acid Synthesis Inhibitors
  • Nicotinic Antagonists
  • Nicotinic Agonists
  • Nicotine
  • Neurotoxicity Syndromes
  • Neuroprotective Agents